Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Type 1 Issues Archives
Print | Email | Share | Comments (0)

What Are the Keys to Preventing Diabetic Kidney Disease?


Oct 1, 2004

How and when do we screen for microalbuminuria?

Annual screening for microalbuminuria (low levels of protein in the urine, indicating early signs of kidney disease) in type 1 diabetes should begin with puberty and/or after five-year disease duration of diabetes.

In patients with type 2, screening should begin at the time of diagnosis.

Consider an ACE Inhibitor

Numerous scientific studies have demonstrated that angiotensin converting enzyme (ACE) inhibitors, such as Vasotec, Altace, lisinopril and others, are the antihypertensive drugs of choice in all patients with diabetes. They reduce microalbuminuria, which is the hallmark of early diabetic kidney disease (nephropathy).

Therefore, the American Diabetes Association’s Standards of Care recommends these medications for all nonpregnant adult patients with diabetes.

Lifetime therapy with the drug is required.

Once begun, the dosage of the ACE inhibitor should be increased to the maximum tolerable dose for the greatest efficacy.

Possible reasons for the failure of ACE inhibitors to reduce microalbumin include:

  • Inadequate dose
  • Excess salt (sodium) in the diet
  • Another cause of kidney disease (in addition to diabetes)
  • Advanced kidney disease (serum creatinine over 3)

Or Maybe an ARB

If ACE inhibitors cannot be tolerated, one of the angiotensin receptor blockers (ARBs), such as Cozaar and Diovan, should be substituted.

This group of drugs has also been demonstrated to reduce albuminuria and prevent kidney failure in both type 1 and type 2 diabetes. In certain cases, physicians may prescribe both classes of drugs for patients with diabetic nephropathy or hypertension.

Other anti-hypertensive agents may be useful, but none have yet been shown to be equivalent to the ACE inhibitors or the ARB drugs in preventing or reducing diabetic nephropathy.

What are the factors that contribute to diabetic kidney disease?

Non-modifiable risk factors (you can’t change these)

  • Older age
  • Longer duration of diabetes
  • Genetic profile

Modifiable risk factors (you can lower these risks)

  • Hypertension
  • Hyperglycemia (A1Cs above 7%)
  • Cholesterol disorders
  • Smoking
  • Frequent urinary tract infections

Categories: A1c Test, Diabetes, Diabetes, Kidney Care (Nephropathy), Type 1 Issues, Type 2 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Oct 1, 2004

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.